1 – 10 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Successful treatment of HCV-associated B-cell non-Hodgkin lymphomas with direct-acting antiviral agents
- Cessation of spread as a treatment objective in vitiligo: perception from the patients' point of view
- The many faces of IL-17 in inflammatory skin diseases
- Galectin-3 in renal pathology: more than just an innocent bystander?
- Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo
- Pyoderma gangrenosum with granuloma formation: not always a benign disorder
- 2015
- Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma
- Why treatments do(n't) work in vitiligo: an autoinflammatory perspective
- Behind the scenes of vitamin D binding protein: more than vitamin D binding
- Glycation of nail proteins: from basic biochemical findings to a representative marker for diabetic glycation-associated target organ damage